Product Description
Haemostatics are applications designed to stem blood-flow through the accelerated promotion of clotting. Topical hemostatic agents can be divided into three basic categories: fibrin sealants; autologous platelet gel; and commercial derivatives of collagen, gelatin, and cellulose that provide a matrix for endogenous coagulation.
The Hemostatic Agents market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Hemostatic Agents market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Hemostatic Agents Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Hemostatic Agents market are:
B.Braun Melsungen AG
Hemostasis, LLC
Pfizer Inc
Cryolife, Inc.
Atrium Medical Corporation
Advanced Medical Solutions Group
Johnson and Johnson Services Inc
Equimedical
Covidien PLC.
Vascular Solutions, Inc
Z-Medica LLC
Marine Polymer Technologies
Sanofi Group
Gelita GmbH
Mallinckrodt Plc
C.R. Bard Incorporation
Integra Life Sciences Corporation
Baxter International Incorporation
Most important types of Hemostatic Agents products covered in this report are:
Thrombin
Oxidized Regenerated Cellulose
Combination
Gelatin
Collagen
Other
Most widely used downstream fields of Hemostatic Agents market covered in this report are:
Hospitals
Surgical Centers
Nursing Homes
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.